EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 40 / No 2 (June 2008) J Extra Corpor Technol, 40 2 (2008) 116-122 References
Free Access
Issue
J Extra Corpor Technol
Volume 40, Number 2, June 2008
Page(s) 116 - 122
DOI https://doi.org/10.1051/ject/200840116
Published online 15 June 2008
  1. Hyers TM. Management of venous thromboembolism: past, present, and future. Arch Intern Med. 2003;163:759–68. [CrossRef] [PubMed] [Google Scholar]
  2. Spiess BD. Update on heparin-induced thrombocytopenia and cardiovascular interventions. Semin Hematol. 2005;42:S22–7. [CrossRef] [Google Scholar]
  3. Rice L. Evolving management strategies for heparin-induced thrombocytopenia. Semin Hematol. 2005;42:S15–21. [CrossRef] [Google Scholar]
  4. Deitcher SR, Carman TL. Heparin-induced thrombocytopenia: natural history, diagnosis, and management. Vasc Med. 2001;6:113–9. [CrossRef] [PubMed] [Google Scholar]
  5. Warkentin TE, Sheppard JA, Horsewood P, et al. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96:1703–8. [CrossRef] [PubMed] [Google Scholar]
  6. Hourigan LA, Walters DL, Keck SA, Dec GW. Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients. J Heart Lung Transplant. 2002;21:1283–9. [CrossRef] [PubMed] [Google Scholar]
  7. Anonymous. American Heart Association: Heart Disease and Stroke Statistics–2005 Update. Dallas, TX: American Heart Association; 2005. [Google Scholar]
  8. Bartholomew JR, Begelman SM, Almahameed A. Heparin-induced thrombocytopenia: principles for early recognition and management. Cleve Clin J Med. 2005;72(Suppl 1):S31–6. [CrossRef] [PubMed] [Google Scholar]
  9. Levy JH, Zaidan JR, Faraj B. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. Anesth Analg. 1986;65:739–42. [Google Scholar]
  10. Weiler JM, Gellhaus MA, Carter JG, et al. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol. 1990;85:713–9. [CrossRef] [Google Scholar]
  11. Saiah E, Soares C. Small molecule coagulation cascade inhibitors in the clinic. Curr Top Med Chem. 2005;5:1677–95. [CrossRef] [Google Scholar]
  12. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med. 2005;353:1028–40. [CrossRef] [PubMed] [Google Scholar]
  13. Brighton TA. The direct thrombin inhibitor melagatran/ximelagatran. Med J Aust. 2004;181:432–7. [CrossRef] [PubMed] [Google Scholar]
  14. Gustafsson D. Oral direct thrombin inhibitors in clinical development. J Intern Med. 2003;254:322–34. [CrossRef] [PubMed] [Google Scholar]
  15. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg. 2003;76:638–48. [CrossRef] [Google Scholar]
  16. Koster A, Chew D, Grundel M, et al. Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesth Analg. 2003;96:383–6. [Google Scholar]
  17. Elgendy S, Deadman J, Claeson G. New peptide boronic acid inhibi-tors of thrombin. Adv Exp Med Biol. 1993;340:173–8. [CrossRef] [PubMed] [Google Scholar]
  18. Walenga JM, Bakhos M, Messmore HL, Fareed J, Pifarre R. Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model. Ann Thorac Surg. 1991;51:271–7. [CrossRef] [Google Scholar]
  19. DeAnda AJr, Coutre SE, Moon MR, et al. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. Ann Thorac Surg. 1994;58:344–50. [CrossRef] [Google Scholar]
  20. Chomiak PN, Walenga JM, Koza MJ, et al. Investigation of a thrombin inhibitor peptide as an alternative to heparin in cardiopulmonary bypass surgery. Circulation. 1993;88:II407–12. [PubMed] [Google Scholar]
  21. Rikitake K, Okazaki Y, Naito K, et al. Heparinless cardiopulmonary bypass with argatroban in dogs. Eur J Cardiothorac Surg. 2004;25: 819–24. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.